Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma

Targeting key genes that play dominant roles in T cell dysfunction is an efficient strategy for cancer immunotherapy. Here, we aimed to investigate the role of TPX2 in the antitumor effect of CD8 + T cells in hepatocellular carcinoma (HCC). Flow cytometry was used to assay the level of cell surface...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaochen, Wang, Jianchu, Shen, Haiyuan, Luo, Zongjiang, Lu, Xiaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913637/
https://www.ncbi.nlm.nih.gov/pubmed/35273149
http://dx.doi.org/10.1038/s41419-022-04645-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913637/
https://www.ncbi.nlm.nih.gov/pubmed/35273149
http://dx.doi.org/10.1038/s41419-022-04645-8

Ejemplares similares